Trial Profile
A study evaluating drug drug interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2016
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Cobicistat/darunavir; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 28 Dec 2016 New trial record
- 20 Dec 2016 Results published in the Journal of Antimicrobial Chemotherapy